| 摘要 |
<p>The present invention relates to modified release oral formulation of a triptan or its pharmaceutically acceptable salts, esters, solvates and derivatives thereof. More particularly, the present invention relates to modified release oral formulation of a triptan or its pharmaceutically acceptable salts, esters, solvates and that provide improved bio-availability and absorption. The present invention also relates to method of treating patients suffering from acute and chronic migraine associated with or without aura, cluster headache and related symptoms. Further the present invention also relates to process of preparation of such compositions</p> |
